ReadYourDNA

Talinolol

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Talinolol

What it is

Talinolol is a beta-1 selective beta blocker that was used in Germany for high blood pressure and heart rhythm problems under the name Cordanum. It is now mainly known as a research tool: because it is barely broken down and moved almost entirely by transporters, it is used to study the drug pump P-glycoprotein (ABCB1) in the gut.

How genes come into it

Talinolol is hardly broken down by enzymes; its absorption and clearance depend on the transporters ABCB1, ABCC2 and ABCG2. Studies, mostly in healthy volunteers, linked variants in these transporter genes to its blood levels. There is no CPIC or DPWG guideline.

What research found

Every published finding on gene variants and Talinolol. Upload your DNA file to see which of these rows apply to you.

Rated evidence (2 rated variants)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

ABCC2 rs2273697: Level 3. Metabolism/PK. 2.

ABCB1 rs1045642: Level 3. Other. 1.

Metabolism (8 findings)

Studies of how quickly the body processes this medication.

ABCB1 rs1045642: Genotype AA is associated with increased clearance of talinolol in healthy individuals as compared to genotypes AG + GG.

ABCB1 rs1128503: Allele A is not associated with clearance of talinolol in healthy individuals as compared to allele G.

ABCB1 rs2032582: Allele C is not associated with clearance of talinolol in healthy individuals as compared to allele A.

ABCB5 rs17143212: Allele T is not associated with clearance of talinolol in healthy individuals as compared to allele C.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Beta Blockers (class) (Beta Blockers)

Betapace (Beta Blockers)

Bucindolol (Beta Blockers)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com